MDM2 and cervical cancer: The results show that by inhibiting the FRA1/MDM2/p53 pathway, LPS can inhibit the aerobic oxidation, promote the glycolysis and the pentose phosphate pathway (PPP) as well as promote the malignant process of cervical cancer cells.